scholarly journals Persistent N2 disease after neoadjuvant chemotherapy for non–small-cell lung cancer

2011 ◽  
Vol 142 (5) ◽  
pp. 1175-1179 ◽  
Author(s):  
Kristin A. Higgins ◽  
Junzo P. Chino ◽  
Neal Ready ◽  
Mark W. Onaitis ◽  
Mark F. Berry ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
N2 Disease

Outcome of surgery for non-small cell lung cancer with pathological N2 disease

Lung Cancer ◽  
2021 ◽  
Vol 156 ◽  
pp. S68-S69
Author(s):  
Abdelrahman Elsayed Elsayed ◽  
Hesham Ahmed Ahmed ◽  
Devan Limbachia Limbachia ◽  
Mohammad Hawari Hawari
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
N2 Disease ◽  
Outcome Of Surgery

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer

2014 ◽  
Vol 21 (2) ◽  
pp. 423-431 ◽  
Author(s):  
Eszter Podmaniczky ◽  
Katalin Fábián ◽  
Judit Pápay ◽  
Rita Puskás ◽  
Márton Gyulai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Ercc1 Expression

18. NY-ESO-1 as a predictive marker for neoadjuvant chemotherapy in stage 3a non- small-cell lung cancer (NSCLC)

Pathology ◽  
2012 ◽  
Vol 44 ◽  
pp. S110
Author(s):  
S. Deb ◽  
T. John ◽  
Y.T. Chen ◽  
A. Azad ◽  
M.H.W. Starmans ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Predictive Marker ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document